Loading…
WELCOME TO LEAD WITH LOVE

Our intention with this gathering is to inspire participants to find what lights them up and to share that more effectively with the world. We will be exploring Mind, Body and Spirit during these 4-days together including time in nature, lunch and dinner conversation, and workshops with global thought leaders. The base will be two heart-opening yoga classes per day as well as thoughtful, curated conversations and workshops.

This transformational event supports Aspen City of Wellbeing, a non-profit organization dedicated to shifting culture towards an optimal state of wellbeing for all.

Lead With Love, October 26th-29th 2017. 

avatar for Stacy Tucker

Stacy Tucker

Almeda
Co-founder
stacy@almedalabs.com
Stacy Tucker RN is a dynamic entrepreneur and health expert based in Kansas City. As a spiritual scientist and nurse trained in trauma and critical care, she utilizes her expertise to support next generation biomedical research. As a proactive healthcare leader with an exceptional track record of entrepreneurship and scientific rigor, she supports high performing executives in learning resilience and self-directed care by incorporating an East meets West approach, focusing on utilizing nutrition to boast metabolic performance and breath to support cognitive challenges. She utilizes Accupuncture, Therapeutic Touch, Reiki, Yoga, Meditation in conjuction with western medicine, which has enabled her to deal with trauma from a pragmatic perspective. As an lifelong learner, she helped support and also participated in the cutting-edge global research study ‘Self Directed Biological Transformation” (SBTI). The SBTI was Chaired by Dr. Rudy Tanzi of Harvard Medical School and Dr. Deepak Chopra. The goal was to determine whether the practices of Ayurveda, meditation, and yoga can reverse biological markers of aging, alter cellular biology, genomics, and the microbiome.

In 2016, Stacy co-founded Almeda Labs, a nutri-biotech company based in Kansas City and partners with leading scientists and biotech companies. Her research is focused in the area of type-2 diabetes and epigenetics, which is useful in measuring the effects of preventable disease modalities from studying the pressures and paradigms of past trauma.